{
    "Trade/Device Name(s)": [
        "Optilite Low Level Albumin Kit",
        "Optilite\u00ae Low Level Albumin Kit"
    ],
    "Submitter Information": "The Binding Site Ltd.",
    "510(k) Number": "K153560",
    "Predicate Device Reference 510(k) Number(s)": [
        "K972929",
        "K964062",
        "K964065",
        "K110035",
        "K121045"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DCF"
    ],
    "Summary Letter Date": "July 22, 2016",
    "Summary Letter Received Date": "July 26, 2016",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5040"
    ],
    "Regulation Name(s)": [
        "Albumin immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Albumin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Urine",
        "CSF"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Binding Site Optilite analyser",
        "Optilite Analyser",
        "Indiko"
    ],
    "Method(s)/Technology(ies)": [
        "Quantitative immunoturbidimetry",
        "Turbidimetry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Optilite Low Level Albumin Kit, a quantitative immunoturbidimetric assay for albumin measurement in CSF, urine, and serum using the Binding Site Optilite analyser.",
    "Indications for Use Summary": "Quantitative in vitro measurement of albumin in CSF, urine, and serum using the Binding Site Optilite analyser to aid in the diagnosis of kidney and intestinal diseases, used in conjunction with other laboratory and clinical findings.",
    "fda_folder": "Immunology"
}